Trial-defined disease progression in multiple sclerosis is a poor measure of permanent disability progression. | AVESİS

Karadeniz Technical University Research Information System

Trial-defined disease progression in multiple sclerosis is a poor measure of permanent disability progression.

Copy For Citation

Butzkueven H., Mechati S., Hoffmann M. W., Arruda W., Boz C., Bacile E., ...More

59th Annual Meeting of the American-Academy-of-Neurology, Massachusetts, United States Of America, 28 April - 05 May 2007, vol.68

Publication Type: Conference Paper / Summary Text
Volume: 68
City: Massachusetts
Country: United States Of America
Karadeniz Technical University Affiliated: Yes